PEAU D'ORANGE
Clinical trials for PEAU D'ORANGE explained in plain language.
Never miss a new study
Get alerted when new PEAU D'ORANGE trials appear
Sign up with your email to follow new studies for PEAU D'ORANGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy shows promise in controlling advanced breast cancer
Disease control OngoingThis study tests whether the immunotherapy drug pembrolizumab can help control advanced breast cancer in patients whose disease has not worsened after initial chemotherapy. It includes 71 adults with either inflammatory breast cancer or triple-negative breast cancer that has spre…
Matched conditions: PEAU D'ORANGE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug combo battle against Fast-Moving breast cancer
Disease control OngoingThis study compares two different chemotherapy combinations given before surgery for a fast-growing, hard-to-treat type of breast cancer called triple-negative inflammatory breast cancer. Researchers want to see if adding a targeted drug called panitumumab to standard chemotherap…
Matched conditions: PEAU D'ORANGE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC